Insider Trades of BARRETT M JAMES
Click on the column header to resort 'ascending (^) or descending (v).
Individual Insider Trades
| Company | Relation | Last Date | Tran | OwnerType | Shares Traded |
Last Price | Shares Held |
|---|---|---|---|---|---|---|---|
| FUSION-IO, INC. | Beneficial Owner (10%) | 06/14/2011 | Acquisition (Non Open Market) | indirect | 25,480,186 | 0 | 25,829,872 |
| TESARO, INC. | Beneficial Owner (10%) | 07/03/2012 | Acquisition (Non Open Market) | indirect | 10,388,144 | 0 | 10,388,144 |
| MILLENNIAL MEDIA INC. | Beneficial Owner (10%) | 04/03/2012 | Acquisition (Non Open Market) | indirect | 9,794,401 | 0 | 9,794,401 |
| SUPERNUS PHARMACEUTICALS INC | Director | 05/04/2012 | Acquisition (Non Open Market) | indirect | 6,241,250 | 0 | 6,241,250 |
| OMTHERA PHARMACEUTICALS, INC. | Beneficial Owner (10%) | 04/16/2013 | Acquisition (Non Open Market) | indirect | 5,208,409 | 0.01 | 5,208,213 |
| FUSION-IO, INC. | Beneficial Owner (10%) | 09/04/2012 | Disposition (Non Open Market) | indirect | 4,545,000 | 0 | |
| SUPERNUS PHARMACEUTICALS INC | Director | 05/04/2012 | Buy | indirect | 4,400,000 | 5 | 10,641,250 |
| WORKDAY, INC. | Beneficial Owner (10%) | 04/10/2013 | Acquisition (Non Open Market) | indirect | 2,350,455 | 0 | 2,321,212 |
| WORKDAY, INC. | Beneficial Owner (10%) | 04/09/2013 | Acquisition (Non Open Market) | indirect | 2,350,162 | 0 | 2,321,212 |
| WORKDAY, INC. | Beneficial Owner (10%) | 04/09/2013 | Disposition (Non Open Market) | indirect | 2,344,424 | 0 | |
| WORKDAY, INC. | Beneficial Owner (10%) | 04/10/2013 | Disposition (Non Open Market) | indirect | 2,344,424 | 0 | |
| HYPERION THERAPEUTICS INC | Beneficial Owner (10%) | 07/31/2012 | Acquisition (Non Open Market) | indirect | 2,306,115 | 0 | 2,384,221 |
| CLOVIS ONCOLOGY, INC. | Director | 11/21/2011 | Acquisition (Non Open Market) | indirect | 2,103,372 | 0 | 2,103,372 |
| MILLENNIAL MEDIA INC. | Beneficial Owner (10%) | 10/29/2012 | Sell | indirect | 1,597,787 | 13.4425 | 8,196,614 |
| AUDIENCE INC | Beneficial Owner (10%) | 02/15/2013 | Disposition (Non Open Market) | indirect | 1,414,000 | 0 | |
| CLOVIS ONCOLOGY, INC. | Director | 11/21/2011 | Buy | indirect | 1,316,299 | 13 | 3,419,671 |
| FUSION-IO, INC. | Beneficial Owner (10%) | 11/28/2011 | Sell | indirect | 1,296,109 | 31.68 | 87,717 |
| TESARO, INC. | Beneficial Owner (10%) | 07/03/2012 | Buy | indirect | 1,111,111 | 13.5 | 11,499,255 |
| FUSION-IO, INC. | Beneficial Owner (10%) | 02/02/2012 | Disposition (Non Open Market) | indirect | 1,020,000 | 0 | |
| FUSION-IO, INC. | Beneficial Owner (10%) | 02/07/2012 | Disposition (Non Open Market) | indirect | 1,010,000 | 0 |
Latest News Headlines
California Exchange May Have Lower Health Insurance Premiums Than Expected 2:01PM ET - Dow Jones Business News
Hovnanian Enterprises Announces Second Quarter Fiscal Year 2013 Earnings Release and Conference Cal 2:00PM ET - GlobeNewswire
Goldman Say-on-Pay Measure Approved 1:55PM ET - Dow Jones Business News
AT&T Imposes New Monthly Administrative Fee for Wireless Users 1:54PM ET - Dow Jones Business News
2nd UPDATE: China Clears Boeing 787s for Commercial Service 1:53PM ET - Dow Jones Business News
View All